Recently, the European Parliament was presented with the results of an important European foresight exercise on the future of rare disease policy called Rare2030. Our colleagues from the Netherlands describe this policy and its recommendations here: https://www.socialpharmaceuticalinnovation.org/post/rare-disease-foresight-what-should-future-rare-disease-policy-look-like
Share with us below what you think of these policy recommendations.